Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease
Authors
Keywords
-
Journal
DARU-Journal of Pharmaceutical Sciences
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-01
DOI
10.1007/s40199-023-00484-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy
- (2022) Guyi Wang et al. Frontiers in Pharmacology
- One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China
- (2022) Yu-Hui Liu et al. JAMA Neurology
- Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition
- (2022) Jimmy Lu et al. Frontiers in Chemistry
- Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study
- (2022) Adam Hermawan et al. Scientific Reports
- Targeting cyclooxygenase enzyme for the adjuvant COVID ‐19 therapy
- (2021) Parteek Prasher et al. DRUG DEVELOPMENT RESEARCH
- Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
- (2021) Vicky Mody et al. Communications Biology
- Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
- (2021) Hylemariam Mihiretie Mengist et al. Frontiers in Pharmacology
- Cancer as a prospective sequela of long COVID‐19
- (2021) Geetanjali Saini et al. BIOESSAYS
- Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
- (2021) C. Joaquín Cáceres et al. Scientific Reports
- Novel SPTBN2 gene mutation and first intragenic deletion in early onset spinocerebellar ataxia type 5
- (2021) Romina Romaniello et al. Annals of Clinical and Translational Neurology
- The Deadly Duo of COVID-19 and Cancer!
- (2021) Vivek R. Bora et al. Frontiers in Molecular Biosciences
- Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms
- (2021) Nicolas Hoertel et al. MOLECULAR PSYCHIATRY
- Prediction of hERG inhibition of drug discovery compounds using biomimetic HPLC measurements
- (2021) Chrysanthos Stergiopoulos et al. ADMET and DMPK
- Cytochrome P450 Enzymes and Drug Metabolism in Humans
- (2021) Mingzhe Zhao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
- (2021) Jan Wenzel et al. NATURE NEUROSCIENCE
- Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- The Genomic Physics of COVID-19 Pathogenesis and Spread
- (2021) Ang Dong et al. Cells
- Mitochondrial and Oxidative Unbalance in Placentas from Mothers with SARS-CoV-2 Infection
- (2021) Chiara Mandò et al. Antioxidants
- Assessment of Cognitive Function in Patients After COVID-19 Infection
- (2021) Jacqueline H. Becker et al. JAMA Network Open
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy
- (2020) Szymon J. Szymura et al. BMC BIOLOGY
- COVID‐19 and (hydroxy)chloroquine–azithromycin combination: Should we take the risk for our patients?
- (2020) Hervé Javelot et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
- (2020) Aleix Gimeno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Artificial intelligence approach fighting COVID-19 with repurposing drugs
- (2020) Yi-Yu Ke et al. Biomedical Journal
- Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
- (2020) Muhammad Tahir ul Qamar et al. Journal of Pharmaceutical Analysis
- Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations
- (2020) Catia Marzolini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease
- (2020) Mahmoud Kandeel et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
- (2020) Julien Andreani et al. MICROBIAL PATHOGENESIS
- Acute Cerebellar Ataxia in COVID-19 infection; a case report.
- (2020) Adriana Povlow et al. JOURNAL OF EMERGENCY MEDICINE
- The BioGRID database: A comprehensive biomedical resource of curated protein, genetic and chemical interactions
- (2020) Rose Oughtred et al. PROTEIN SCIENCE
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
- (2020) Lifeng Fu et al. Nature Communications
- Noscapine anticancer drug designed with ionic liquids to enhance solubility: DFT and ADME approach
- (2020) Ajay Kumar et al. JOURNAL OF MOLECULAR LIQUIDS
- Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment
- (2020) Paola Magro et al. Biomedical Journal
- LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease
- (2019) Jie Cui et al. Frontiers in Physiology
- Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer
- (2018) Han-Rong Zhang et al. GYNECOLOGIC ONCOLOGY
- Negative regulation of MAVS-mediated antiviral signaling by the mitochondrial protein LRPPRC during HCV infection
- (2018) Giulia Refolo et al. HEPATOLOGY
- Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities
- (2018) Saba Munawar et al. Frontiers in Pharmacology
- A new semi-automated workflow for chemical data retrieval and quality checking for modeling applications
- (2018) Domenico Gadaleta et al. Journal of Cheminformatics
- The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders
- (2018) Inês S. Amorim et al. Frontiers in Genetics
- Succinate dehydrogenase (SDH)-deficient neoplasia
- (2017) Anthony J Gill HISTOPATHOLOGY
- ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication
- (2017) Harini Sooryanarain et al. JOURNAL OF VIROLOGY
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- The integrated stress response
- (2016) Karolina Pakos‐Zebrucka et al. EMBO REPORTS
- Computational Exploration of Molecular Scaffolds in Medicinal Chemistry
- (2016) Ye Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
- (2015) Douglas E. V. Pires et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular fingerprint similarity search in virtual screening
- (2015) Adrià Cereto-Massagué et al. METHODS
- Mitochondrial DNA stress primes the antiviral innate immune response
- (2015) A. Phillip West et al. NATURE
- Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade
- (2015) Maria Perez-Gomez et al. Journal of Clinical Medicine
- cytoHubba: identifying hub objects and sub-networks from complex interactome
- (2014) Chia-Hao Chin et al. BMC Systems Biology
- Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation
- (2014) Huu B. Ngo et al. Nature Communications
- Molecular Similarity in Medicinal Chemistry
- (2013) Gerald Maggiora et al. JOURNAL OF MEDICINAL CHEMISTRY
- Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes
- (2013) Timothy J. Sullivan et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking
- (2012) Michael M. Mysinger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
- (2012) Y. Kim et al. JOURNAL OF VIROLOGY
- Lopinavir/Ritonavir
- (2010) Jamie D. Croxtall et al. DRUGS
- Consensus Superiority of the Pharmacophore-Based Alignment, Over Maximum Common Substructure (MCS): 3D-QSAR Studies on Carbamates as Acetylcholinesterase Inhibitors
- (2009) Shailendra S. Chaudhaery et al. Journal of Chemical Information and Modeling
- Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast
- (2009) Riham H. El Khouli et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now